Intrinsic Value of S&P & Nasdaq Contact Us

Doximity, Inc. DOCS NYSE

NYSE • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
88/100
6/7 Pass
SharesGrow Intrinsic Value
$46.95
+111%
Analyst Price Target
$45.87
+106.2%

Doximity, Inc. (DOCS) generated $60.89M in operating cash flow for quarter ending 2025-12-31. After capital expenditures of $1.97M, free cash flow was $62.86M.

Free cash flow margin was 34% of revenue. Cash conversion ratio was 0.99x, suggesting some earnings are non-cash.

The company returned $196.88M in share buybacks to shareholders during the quarter.

Criteria supported by this page:

  • HEALTH (100/100, Pass) — demonstrate the company can comfortably service its debt
  • MOAT (66/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
  • INCOME (100/100) — Cash conversion ratio was 0.99x suggests some earnings are non-cash items

Overall SharesGrow Score: 88/100 with 6/7 criteria passed.

SharesGrow 7-Criteria Score
88/100
SG Score
View full scorecard →
VALUE
83/100
Price-to-Earnings & upside
→ Valuation
FUTURE
85/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
Proven by this page
~
MOAT
66/100
Proven by this page
GROWTH
80/100
→ Income
INCOME
100/100
→ Income
Doximity, Inc. Cash Flow History
Metric TTM Q3 FY2026 Q2 FY2026 Q1 FY2026 Q4 FY2025
Operating Cash Flow $315.42M$60.89M$93.94M$62.1M$98.49M
Capital Expenditure $-2.37M$1.97M$-2.37M$-1.97M$0.00
Free Cash Flow $313.05M$62.86M$91.58M$60.14M$98.49M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message